LifeArc-CSO Fund for Scottish Translational Researchers

In association with the Chief Scientist Office (CSO) for the Scottish Government, we are making new funds available to further Scottish research into new clinical interventions for rare diseases. A joint fund of £300,000 is available to support two-three projects led by researchers in Scottish institutes or the NHS that will accelerate the translation of strong discovery science. The intention is that the funding will progress projects to a point where additional substantive funding could be secured.

This call is now closed.

Successful projects will:

  • Address a rare disease medical need
  • Have a strong scientific rationale
  • Be target driven with a credible delivery plan
  • Be on a translational pathway towards clinical utility
  • Be led by a salaried member of staff at a Scottish University or NHS Board
  • Cost in the region of £100,000

All modalities of intervention are eligible for support from the scheme. The following activities are not eligible for support:

  • Fundamental or investigative research that does not link to a development plan
  • Studies where the primary purpose is to investigate disease mechanisms

Applicant eligibility

Projects will be led by researchers and/or clinicians in Scotland. Translational research is typically collaborative, bringing together individuals with a range of expertise for development of an intervention, and collaborations with industry and other academic partners are encouraged.

For collaborative applications within Scotland, the grant (and associated funding arrangements) will be made with the lead applicant’s institution. Named academic/clinical collaborators will be permitted from outside Scotland but the lead applicant must be a salaried member of staff at a Scottish University or NHS Board.

Direct costs of research are eligible for support through the scheme.


If you have any questions about the scheme, please contact Dr Rachael Brooker, Senior Business Manager at